High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms

CY Lian, ZZ Zhai, ZF Li, L Wang - Chemico-biological interactions, 2020 - Elsevier
Obesity is characterized by the deposition of excessive body fat, and is caused by energy
imbalance, especially when consuming fat-rich diets. High fat diet (HFD)-associated obesity …

[HTML][HTML] Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention

NF Lange, P Radu, JF Dufour - Journal of hepatology, 2021 - Elsevier
In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with
non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is …

Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications

CD Byrne, G Targher - Diabetes, Obesity and Metabolism, 2022 - Wiley Online Library
Abstract Background/Aim Non‐alcoholic fatty liver disease (NAFLD) affects approximately
25% of the global adult population. The aim of this narrative review is to describe the …

non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations

SA Polyzos, S Kechagias… - Alimentary …, 2021 - Wiley Online Library
Background There are increasing data on the association between non‐alcoholic fatty liver
disease (NAFLD) and cardiovascular diseases (CVD). Aim To summarise evidence on the …

Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis

V Houttu, S Csader, M Nieuwdorp… - Frontiers in …, 2021 - frontiersin.org
Background: With no approved pharmacotherapy to date, the present therapeutic
cornerstone for non-alcoholic fatty liver diseases (NAFLD) is a lifestyle intervention …

The effects of nano-curcumin supplementation on risk factors for cardiovascular disease: a GRADE-assessed systematic review and meta-analysis of clinical trials

D Ashtary-Larky, M Rezaei Kelishadi, R Bagheri… - Antioxidants, 2021 - mdpi.com
Previous studies have indicated that curcumin supplementation may be beneficial for
cardiometabolic health; however, current evidence regarding the effects of its nanorange …

Management of dyslipidemia in patients with non-alcoholic fatty liver disease

A Martin, S Lang, T Goeser, M Demir… - Current atherosclerosis …, 2022 - Springer
Abstract Purpose of Review Patients with non-alcoholic fatty liver disease (NAFLD), often
considered as the hepatic manifestation of the metabolic syndrome, represent a population …

Effects of Mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression analysis of randomized …

T Kawaguchi, M Charlton, A Kawaguchi… - Seminars in Liver …, 2021 - thieme-connect.com
We conducted a meta-analysis to investigate the effects of the Mediterranean Diet (Med-
Diet) on hepatic steatosis and insulin resistance in patients with nonalcoholic fatty liver …

[HTML][HTML] Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

T Reinson, RM Buchanan, CD Byrne - Clinical and molecular …, 2023 - ncbi.nlm.nih.gov
In the last 20 years, noninvasive serum biomarkers to identify liver fibrosis in patients with
non-alcoholic fatty liver disease (NAFLD) have been developed, validated against liver …

Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease

WK Chan, SS Tan, SP Chan, YY Lee… - Journal of …, 2022 - Wiley Online Library
Abstract The Malaysian Society of Gastroenterology and Hepatology saw the need for a
consensus statement on metabolic dysfunction‐associated fatty liver disease (MAFLD). The …